Home › Therapeutic areas › Immunology › Psoriatic Arthritis
Psoriatic Arthritis (3 companies)
Companies with an active program in Psoriatic Arthritis.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| MLTX | MoonLake Immunotherapeutics | DermatologyImmunology Rare | 1 | NDA Submitted | $981M | 4 |
| ORKA | Oruka Therapeutics | DermatologyImmunology Rare | 1 | Phase 2 | $6.81B | 7 |
| PTGX | Protagonist Therapeutics | DermatologyHematology+2 Rare | 1 | Approved | $8.62B | 12 |
No companies match.